目的探讨瘢痕子宫中期妊娠者行米非司酮联合雷佛奴尔引产的可行性及安全性。方法选取瘢痕子宫中期妊娠者106例,口服米非司酮75 mg/12 h,共服150 mg后行雷佛奴尔100 mg羊膜腔内注射,观察记录引产时间、胎盘胎膜娩出情况及出血量并与同期正常妊娠引产组相比较。结果 101例成功,5例失败改行钳刮术,无一例发生子宫破裂,其引产时间、胎盘胎膜娩出情况及出血量两组无明显差别。结论瘢痕子宫中期妊娠者行米非司酮联合雷佛奴尔引产具有临床效果显著,方法简单安全,缩短产程,减轻疼痛,损伤少,出血少等优点,是安全可行的。 Objective To investigate the feasibility and safety of induction of labor with mifepristone and levenurin in hypertrophic scar pregnancy. Methods 106 pregnant women with uterus in the scar were enrolled in this study. Mifepristone (75 mg / 12 h) was given orally for 150 mg and received 100 mg of Levoner 100 mg intramuscularly. The duration of induced labor, the delivery of placental membranes and hemorrhage Volume and with the same period of normal pregnancy induced labor group compared. Results 101 cases were successful, 5 cases failed to divert forceps curettage, no case of uterine rupture occurred, the induction of labor, placental membranes and the amount of bleeding was no significant difference between the two groups. Conclusion It is safe and feasible to use mifepristone combined with Leventon induction of labor in patients with mid-pregnancy uterine scar. The method has the advantages of simple and safe method, shortened labor process, less pain, less injury and less bleeding.